# Pneumotox. vs ASRA Coags

The clearest difference is rating: Pneumotox. at 4.9 against ASRA Coags's 1.3. Pneumotox. also leads on review sentiment (50% vs 9%) and monetization model (free vs subscription). ASRA Coags's advantage is update cadence (every 3 months vs every 42 months) and ratings volume (414 vs 7). On price, ads, in-app purchases and device support there is nothing between them.

Both are free to download. Neither carries in-app purchases, so what you see is what you pay.

Pneumotox. holds the better App Store score, 4.9 against 1.3. That said, the two scores are not equally well evidenced: ASRA Coags has 414 ratings behind it against 7, so its average is the more settled of the two. Written reviews point the same way: 50% of Pneumotox.'s written reviews are positive against 9% of ASRA Coags's.

Pneumotox. ships an update every 42 months, ASRA Coags every 3 months. The most recent releases landed on October 24, 2026 and November 1, 2026 respectively.

## The numbers

| Metric | Pneumotox. | ASRA Coags |
| --- | --- | --- |
| Price | Free | Free |
| Rating | **[4.9 (7 ratings)](https://appshunter.io/ios/app/pneumotox/id495707401/reviews)** | [1.3 (414 ratings)](https://appshunter.io/ios/app/asra-coags/id858796572/reviews) |
| Number of ratings | 7 | **414** |
| Positive reviews | **50.0% of reviews** | 8.9% of reviews |
| In-app purchases | No | No |
| Ads | No | No |
| Update frequency | Every 42 months | **Every 3 months** |
| Monetization | **Free** | Subscription |
| Size | 48 MB | 27 MB |
| Requires iOS | 16.4 | **13.4** |
| Devices | iPhone, iPad | iPhone, iPod |
| Age rating | 17+ | 17+ |
| Developer | [Philippe Camus](https://appshunter.io/developer/1438857331) | [American Society of Regional Anesthesia and Pain Medicine](https://appshunter.io/developer/858796575) |

## What reviewers say

### Pneumotox.

[App page](https://appshunter.io/ios/app/pneumotox/id495707401)

This app aids in diagnosing respiratory and cardiac diseases suspected of being drug-induced. It provides extensive information and bibliography from over 35,000 reviewed references, organized by causative drugs and respiratory patterns. It helps assess drug causality and offers diagnostic prompts.

**Highlights:** Diagnose drug-induced respiratory diseases, Extensive bibliography from 35,000+ references, Organized by causative drugs and respiratory patterns, Drug causality assessment tool, Diagnostic prompts and Naranjo scale integration, Information on various drug administration routes

**Features:** macOS Compatibility, Vision Pro support

**In-app purchases:** none


### ASRA Coags

[App page](https://appshunter.io/ios/app/asra-coags/id858796572)

This app provides quick access to anticoagulation guidelines for regional anesthesia and interventional pain procedures. It offers drug-specific summaries, recommendations based on procedure type, and detailed information on medication mechanisms and guideline documents.

**Highlights:** Anticoagulation guideline reference, Drug-specific summary information, Regional anesthesia guidelines, Interventional pain guidelines, Search by drug or procedure, Recommendations by block and intervention type

**Features:** Apple Wallet, Vision Pro support

**In-app purchases:** none


## Frequently asked questions

### Is Pneumotox. free?

Pneumotox. is free to download, with no in-app purchases.

### Is ASRA Coags free?

ASRA Coags is free to download, with no in-app purchases.

### Which has better reviews, Pneumotox. or ASRA Coags?

Pneumotox. is rated higher. Pneumotox. averages 4.9 out of 5 from 7 ratings, while ASRA Coags averages 1.3 from 414 ratings.

### Do Pneumotox. or ASRA Coags have ads?

Neither Pneumotox. nor ASRA Coags shows ads.

### Which is updated more often, Pneumotox. or ASRA Coags?

Pneumotox. ships an update every 42 months, and ASRA Coags every 3 months. Most recently, Pneumotox. was updated on October 24, 2026 and ASRA Coags on November 1, 2026.

---

*Compared by [AppsHunter](https://appshunter.io/) from daily US App Store data. Review summaries are generated from verbatim App Store reviews.*